LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.
Huntington Disease
LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.
Longitudinal Endpoint Assessment of Disease Burden in HD
-
Huntington Study Group, Rochester, New York, United States, 14618
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Huntington Study Group,
Jamison Seabury, PRINCIPAL_INVESTIGATOR, University of Rochester Center for Health + Technology
2026-12